- Home
- PROK vs CMDB Comparison
PROK vs CMDB Comparison
Compare PROK & CMDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROK | CMDB |
|---|---|---|
| Founded | 2015 | 2023 |
| Country | United States | Monaco |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.1M | 342.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PROK | CMDB |
|---|---|---|
| Price | $2.36 | $15.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.40 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 54.8K |
| Earning Date | 11-10-2025 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $744,000.00 | ★ $799,159,000.00 |
| Revenue This Year | $918.66 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 152.53 |
| 52 Week Low | $0.46 | $8.46 |
| 52 Week High | $7.13 | $17.57 |
Technical Indicators
Market Signals| Indicator | PROK | CMDB |
|---|---|---|
| Relative Strength Index (RSI) | 49.85 | N/A |
| Support Level | $2.06 | N/A |
| Resistance Level | $2.29 | N/A |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 50.00 | 0.00 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About CMDB Costamare Bulkers Holdings Limited
Costamare Bulkers Holdings Ltd is an international owner and operator of dry bulk vessels providing multinational transportation of dry bulk commodities for a broad range of customers. Its owned fleet consists of 38 vessels, with a total carrying capacity of approximately 3,017,000 dwt. The company's vessels transport a broad range of bulks across the shipping routes around the world. Iron ore, coal and grain constitute the majority of its cargoes.